Monograph Details
|
|
Hematology
> Immune-mediated blood disorders
|
|
BAYRHO-D FULL DOSE |
| Manufacturer |
|
Bayer Corp, Pharmaceutical Div. |
| Legal Classification |
|
Rx
|
| Generic Name |
|
Rho(D) immune globulin human 300micrograms; for IM inj; solvent/detergent treated. |
| Also |
|
• BAYRHO-D MINI-DOSE
|
| Indications |
|
Preventing Rho(D) sensitization in nonsensitized Rho(D) negative or Du negative patients to the Rho(D) factor, following pregnancy or accidental transfusion. |
| Children |
|
Not recommended. |
| Adults |
|
Each vial or syringe (approx. 300micrograms) prevents sensitization to a volume of up to 15mL of Rh positive red blood cells. Administer IM at 28 weeks of gestation, within 72 hours of an Rh incompatible delivery, miscarriage, abortion, or transfusion accident. |
| Contraindications |
|
Rho(D) positive patients. Pregnancy (Cat.C). |
| Precautions |
|
Live vaccines. Have epinephrine available. |
| Adverse Reactions |
|
Local reactions. |
| How Supplied |
Full Dose (single-dose syringes and vials)—1, 10
Mini-Dose (single-dose syringes)—10 |
|
|
|
|
